These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9167004

  • 1. Laboratory tests for live attenuated poliovirus vaccines.
    Wood DJ, Macadam AJ.
    Biologicals; 1997 Mar; 25(1):3-15. PubMed ID: 9167004
    [Abstract] [Full Text] [Related]

  • 2. New assays for the quality control of live oral poliovirus vaccine.
    Furesz J, Levenbook I.
    Acta Microbiol Immunol Hung; 1998 Mar; 45(3-4):391-9. PubMed ID: 9873944
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of new approaches to poliovirus vaccine neurovirulence tests.
    Wood DJ.
    Dev Biol Stand; 1996 Mar; 86():79-83. PubMed ID: 8785995
    [Abstract] [Full Text] [Related]

  • 4. Neurovirulence.
    Wood D.
    Dev Biol Stand; 1999 Mar; 101():127-9. PubMed ID: 10566785
    [Abstract] [Full Text] [Related]

  • 5. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
    Rezapkin GV, Fan L, Asher DM, Fibi MR, Dragunsky EM, Chumakov KM.
    Virology; 1999 May 25; 258(1):152-60. PubMed ID: 10329577
    [Abstract] [Full Text] [Related]

  • 6. Estimation of the neurovirulence of poliovirus by non-radioisotope molecular analysis to quantify genomic changes.
    Horie H, Tano Y, Doi Y, Hashizume S.
    Biologicals; 1998 Dec 25; 26(4):289-97. PubMed ID: 10403032
    [Abstract] [Full Text] [Related]

  • 7. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.
    Taffs RE, Chumakov KM, Rezapkin GV, Lu Z, Douthitt M, Dragunsky EM, Levenbook IS.
    Virology; 1995 Jun 01; 209(2):366-73. PubMed ID: 7778271
    [Abstract] [Full Text] [Related]

  • 8. Attenuation and reversion of the Sabin vaccine strains of poliovirus.
    Minor PD.
    Dev Biol Stand; 1993 Jun 01; 78():17-26. PubMed ID: 8388828
    [Abstract] [Full Text] [Related]

  • 9. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H, Yoshida H, Matsuura K, Miyazawa M, Wakabayashi K, Nomoto A, Hashizume S.
    J Med Virol; 2002 Nov 01; 68(3):445-51. PubMed ID: 12226835
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
    Pavlov DN, Van Zyl WB, Van Heerden J, Kruger M, Blignaut L, Grabow WO, Ehlers MM.
    J Appl Microbiol; 2006 Dec 01; 101(6):1367-79. PubMed ID: 17105568
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the new control methods for oral poliomyelitis vaccine.
    Grachev VP, Karganova GG, Rumyantsev AA, Ivanova OE, Eremeeva TP, Drozdov SG.
    Dev Biol (Basel); 2001 Dec 01; 105():211-7. PubMed ID: 11763330
    [Abstract] [Full Text] [Related]

  • 12. Live-attenuated strains of improved genetic stability.
    Macadam AJ, Ferguson G, Stone DM, Meredith J, Almond JW, Minor PD.
    Dev Biol (Basel); 2001 Dec 01; 105():179-87. PubMed ID: 11763326
    [Abstract] [Full Text] [Related]

  • 13. Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.
    Furesz J, Contreras G.
    Dev Biol Stand; 1993 Dec 01; 78():61-70. PubMed ID: 8388832
    [Abstract] [Full Text] [Related]

  • 14. Genetic basis of attenuation of the Sabin oral poliovirus vaccines.
    Minor PD, Macadam AJ, Stone DM, Almond JW.
    Biologicals; 1993 Dec 01; 21(4):357-63. PubMed ID: 8024751
    [No Abstract] [Full Text] [Related]

  • 15. [Genetic changes in strains of poliovirus type 2 isolated from patients with vaccine-associated paralytic poliomyelitis].
    Sosa-Díaz RY, Más-Lago P, Valdés-Ramírez O, Sarmiento-Pérez L.
    Rev Neurol; 1993 Dec 01; 36(9):812-6. PubMed ID: 12717666
    [Abstract] [Full Text] [Related]

  • 16. Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice.
    Levenbook I, Nomura T.
    Lab Anim Sci; 1997 Apr 01; 47(2):118-20. PubMed ID: 9150487
    [Abstract] [Full Text] [Related]

  • 17. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S, Ota Y, Koike S, Kurata T, Horie H, Nomura T, Hashizume S, Nomoto A.
    Virology; 1995 Feb 01; 206(2):1075-83. PubMed ID: 7856082
    [Abstract] [Full Text] [Related]

  • 18. [Use of molecular biological method (MAPREC-test) for evaluating residual neurovirulence and genetic stability of oral poliovirus vaccine type 3].
    Rumiantsev AA, Grachev VP, Kozlov VG, Karganova GG.
    Vopr Virusol; 2001 Feb 01; 46(6):11-5. PubMed ID: 11785380
    [Abstract] [Full Text] [Related]

  • 19. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC, Modlin JF.
    Pediatrics; 2006 Aug 01; 118(2):611-8. PubMed ID: 16882814
    [Abstract] [Full Text] [Related]

  • 20. Murine neurovirulence studies with a chimeric poliovirus: in vivo generation of a mutant base-paired stable attenuated poliovirus.
    Lee C, Young C.
    Microb Pathog; 1998 Oct 01; 25(4):215-25. PubMed ID: 9817825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.